Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of the endothelial nitric oxide synthase (enos). ADMA is believed to be implicated in angiogenesis because it regulates the nitric oxide biosynthesis; any pathological abnormalities in ADMA play a crucial role in the pathogenesis and progression of atherosclerosis. the aim of the present study was to determine the reference range for plasma concentration of ADMA in a sample of bulgarian population. Patients and methOds: to establish the reference interval of ADMA plasma levels and study the impact of sex and age we recruited 150 healthy subjects of bulgarian nationality aged between 18 and 65 years. The selection criteria for the reference group were made to comply with the generally approved recommendations of the International Federation of Clinical Chemistry (IFCC). Plasma concentrations of ADMA were determined using elIsA assay (DlD, Diagnostics, hamburg, germany). Results: The reference ranges for ADMA, given as 95% of the measured values, were from 0.22 to 0.69 μmol/l. We found no sex-related differences in ADMA concentration (P > 0.05), which obviates the need for separate reference intervals for men and women. single-factor dispersion analysis found no age dependency of ADMA (P > 0.05, f = 1.038) in the studied reference group in the age range 18-65 which makes unnecessary establishment of reference intervals for lower age ranges in this age group. cOnclusiOn: the reference values for ADMA plasma concentrations calculated according to the type of distribution of results can be used as baseline criteria in clinical laboratory studies and for clinical purposes.
IntRoDUCtIon
The endothelium is a key factor in keeping the vascular tone and structure normal. One of the mechanisms through which endothelial dysfunction develops involves elevation of the blood levels of asymmetric dimethylarginine (ADMA). 1 ADMA is a structural analogue of the amino acid L-arginine, but contains two methyl groups and acts as endogenous inhibitor of the endothelial nitric oxide synthase (eNOs). 2 The initial phase in ADMA endogenous formation is the asymmetric dimethylation of L-arginine residues of various cellular proteins by a specific enzyme -the type 1 protein arginine methyltranspherase (PRMTs 1). The product of this reaction, S-adenosyl homocysteine (S-AX), is hydrolysed to L-homocysteine which is then metabolised via the trans-sulphur pathway or re-methylated to L-methionine. Proteolytic degradation of methylated proteins leads to liberation of ADMA to the cytosol. Then it can be realized into the extracellular space into the blood plasma. 3 Approximately 80% of ADMA is metabolised to citrulline and dimethylamine by the enzyme dimethylarginine dimethylaminohydrolase (DDHA). This enzyme's activity modulates the ADMA levels. Approximately 20% of ADMA is excreted in the urine. 4 The activity of eNOs and, hence, the endotheliumdependent vasodilation, is dependent on the ratio of the concentrations of L-arginine and ADMA. L-arginine levels in healthy subjects exceeds those of ADMA, which has an impact on the activity of eNOs towards a normal vascular tone and structure. Elevation of ADMA levels inhibits eNOs causing endothelial dysfunction accompanied by impairment in the endothelium-dependent vasodilation, thrombocyte hyperaggregation, enhanced monocyte adhesion, liberation of free radicals and smooth muscle and cellular proliferation. 5 What method of analysis of ADMA levels would The following variants of the chromatographic analysis are used: high-performance liquid chromatography (HPLC), gas-chromatography (GC), gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-tandem MS). The immunological methods used for determination of ADMA are analytical development which recently has been finding wider application in modern clinical laboratory.
An ELISA assay for determination of ADMA in serum and plasma has been recently developed and validated based on the competitive indirect immunoassay. 6 In an extended survey of the methodological aspects of ADMA quantification J. Horowitz et al. 7 emphasised the considerable advantages of ELISA method: the test is easy to perform, has high efficiency and high sensitivity, and most importantly, it is of practical importance both for routine diagnostic practice and for clinical studies.
The interest toward ADMA has been increasing in the last years. ADMA is now believed to play a significant role in angiogenesis because it physiologically modulates the nitric oxide (NO) biosynthesis, and because any pathological abnormalities in ADMA can critically affect the pathogenesis and progression of atherosclerosis. Evidence has been found of correlation between the high ADMA levels and hypercholesterolemia, hypertension, hyperhomocysteinemia, diabetes mellitus, smoking, heart failure, renal and liver failure, erectile dysfunction, etc. [8] [9] [10] [11] [12] [13] [14] [15] [16] Elevated levels of ADMA correlate with intima-media thickness (IMT) of the carotid artery -the latter being a proven method for clinical assessment of atherosclerosis progression. [17] [18] [19] [20] The correlation of ADMA with cardiovascular morbidity and mortality has been demonstrated in a number of epidemiologic and prospective clinical trials in the recent years. [21] [22] [23] There is also convincing evidence to indicate that ADMA may be correlated with the classic risk factor for ischemic disease. 15, 24, 25 Because of this ADMA is now considered as a marker of endothelial dysfunction, a candidate for a novel cardiovascular risk factor or an independent risk factor.
As there have been no published reference values for plasma concentrations of ADMA in a Bulgarian population quantitated with ELISA, plasma levels of ADMA were studied in 150 healthy subjects of Bulgarian nationality with age-matching lipid profile.
PAtIents AnD MethoDs
One hundred and fifty healthy Bulgarians were recruited to determine the reference range for ADMA plasma levels and investigate the correlation with sex and age. The reference group was selected on criteria consistent with the generally approved recommendations of the International Federation of Clinical Chemistry (IFCC). 25 The contingent consisted of 74 men and 76 women aged between 18 and 65: 120 were younger than 50 and 30 older than 50 (Fig. 1) .
Clinical and routine hematological, biochemical and coagulation tests were performed to assess their health status.
Exclusion criteria were: diabetes mellitus or impaired glucose tolerance: fasting blood glucose > 6.1 mmol/l; LDL cholesterol > 4.1 mmol/l; hypertriglyceridemia -TG > 1.7 mmol/l; obesity -body mass index greater than 26 kg/m 2 ; current smoking or nonsmoking status for the period of study, clinical, instrumental (ECG, stress test) and laboratory evidence of coronary heart disease, hypertension, chronic obstructive pulmonary disease, bronchial asthma, peripheral vascular disease -ankle brachial pressure index < 0.9, chronic renal and liver diseases, systemic diseases of the connective tissues -collagenosis, rheumatoid arthritis, lupus, neoplastic processes, acute inflammation or chronic inflammatory process in active treatment; continuous reception (during the last three months and during ADMA plasma concentrations were determined using ELISA assay (DLD Diagnostica GMBH, Germany) after it was validated locally. Principle: Indirect competitive immunoenzymatic. The method was validated in compliance with the international standard of quality and competence of medical laboratories (BDS/EN/ISO 15189). The following major characteristics of analytic reliability were tested: intra-assay imprecision -CV < 8.2%, interassay imprecision -CV < 11.2%; accuracy -d% < 8.0%; and recovery -92.7%. The method shows high precision; the results are consistent with the recommended minimal non-reproducibility (CV < 20%) for ELISA in studying ADMA as given by the manufacturer.
Venous blood samples were collected in the morning (anticoagulant K3EDTA, 4.5 mmol/l blood, Monovette, Sarstedt) as atraumatically as possible after a 3-day cholesterol and alcohol-free diet, 12-hour fasting and 30-minute rest immediately prior to testing. The samples were centrifuged at 2500 rpm for 10 minutes. The plasma was kept at -20°C for no more than a month until analysed.
The manners of withdrawal, processing and storage of blood samples and the choice of biologic materials were in compliance with the requirements given by the manufacturer and the recommendations of a number of authors to compensate for the factors of result variation and for standardisation of the preanalytical stage. [26] [27] [28] [29] Microsoft Excel 2000 and SPSS 12.0 (Windows XP) were used to analyze the results. The level of statistical significance of hull hypothesis was P < 0.05. The analysis of the effect of sex was determined using the independent sample t-test. The Kolmogorov-Smirnov test was used to analyze the type of distribution of the results. The reference intervals were calculated using the algorithm recommended by IFCC developed for the software programme REFVAL (v. 
ResUlts
We found no statistically significant differences in the values of the studied indexes between men and women which was the reason we used a common group (Table 1) .
The distribution of the results for ADMA according to Kolmogorov-Smirnov was non-normal (р < 0.05, λ = 1.97) (Fig. 2) . The distribution of the results for ADMA became normal after transformation of the data using exponential function to correct the asymmetry and excess. The reference interval for ADMA plasma levels is from 0.22 (90% CI: 0.18-0.25) µmol/l to 0.69 (90% CI: 0.67-0.71) µmol/l. The analysis of the effect of age using a single factor dispersion analysis found no age-related dependency (P > 0.05, F = 1.433) of ADMA in the studied reference group in the age group of 18-65 years which obviates the need to build reference ranges for lower age intervals in this period.
Graphic presentation was used to achieve easier interpretation of the internal structure of the reference interval (Fig. 3) .
The reference range was plotted parallel to The graphic presentation, which actually shows the internal structure of the result distribution, clearly indicates that the results for ADMA have a pronounced left asymmetry and relatively wider confidence interval for lower reference interval. This mode of presenting the reference intervals has the advantage of providing immediate information about the type of distribution, the width and reliability of the reference intervals and the uniqueness of a specific result.
DIsCUssIon
Although establishing reference values is an expensive and time-consuming task their determination is recommended when there is just a small number of parameters, for instance, newly introduced parameters or parameters having genetic heterogeneity. 26 This argues strongly for reference intervals built for a specific population from a specific region and with a specific structure.
The reference values for ADMA we determined are lower than those reported by F. Schulze, et al. 29 in 500 Caucasian subjects using the same IFCC analytical principle and algorithm in the statistical analysis of the results. We think that this finding can be most probably accounted for by the differences in the frequency of genetic polymorphisms and environmental factors. These same researchers found no age differences but reported sex-dependent correlations between ADMA and age in women over the age of 50 in comparison with the men of the same age without the result reaching statistical significance (0.80 vs. 0.73, P = 0.036); they explained this by differences in hormonal status and onset of menopause in women. We also found no sex-related differences in the ADMA mean values although they were slightly higher in women older than 50 but were not statistically significant (0.61 vs. 0.57, Р > 0.05), which obviates the need to assess the parameter by sex. Similar results confirming the absence of sex-related differences in ADMA plasma levels in subjects over the age of 50 have been reported by J. Horowitz et al. 7 Most publications in literature give the mean values for ADMA in control groups of healthy subjects calculated parametrically (± 2SD), without being corrected for the type of distribution of the results. The values we report indicate that there are certain variations connected with the non-Gaussian distribution of the ADMA results, differences in the methods and the analysis of the sample, the impact of the factors determining the biologic variation of the results. 7, 28, [30] [31] [32] ADMA concentrations are especially strongly dependent on the activity of the enzymes that take part in the metabolism of the amino acid L-arginine. In spite of this, in many reports in the literature, the interpretation of the data about ADMA very often SD -standard deviation; 90% CI -90% confidence interval. 
ConClUsIons
The reference values for ADMA plasma levels we determined in the present study are calculated according to the type of result distribution; they can be used as baseline criteria in clinical and laboratory studies and for clinical purposes. The changes in ADMA concentrations between 18 and 65 years of age could not reach statistical significance, hence there is no need to have reference intervals for lower age intervals. The absence of sex-related differences in ADMA concentrations makes unnecessary the building of reference ranges separately for men and women. The graphic model of presenting the reference intervals we used provides immediate information about the type of distribution, the width and reliability of the reference values and makes it possible to visually determine how typical the results in studies of risk populations are.
